Editorial Commentary
Early liquid biopsy in advanced non-small cell lung cancer: insights from the LIBELULE trial
Translational Lung Cancer Research
2026;
15
(1)
:1
.
(31 January 2026)
Lung cancer survivorship: natural language processing for automated abstraction of follow-up computed tomography indication
Translational Lung Cancer Research
2026;
15
(1)
:2
.
(31 January 2026)
Original Article
Artificial intelligence-based density proportion analysis in predicting the invasiveness of neoplastic ground-glass nodules
Translational Lung Cancer Research
2026;
15
(1)
:3
.
(31 January 2026)
A CT imaging-based deep learning model for predicting EGFR and KRAS mutations in non-small cell lung cancer: toward personalized treatment approaches
Translational Lung Cancer Research
2026;
15
(1)
:4
.
(31 January 2026)
Efficacy and safety of lorlatinib in first-line and subsequent-line treatments for patients with ALK-positive non-small cell lung cancer: a single-center real-world study in China
Translational Lung Cancer Research
2026;
15
(1)
:5
.
(31 January 2026)
Prognostic factors of epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor (TKI): a nationwide registry study in China
Translational Lung Cancer Research
2026;
15
(1)
:6
.
(31 January 2026)
Impact of pleural lavage fluid volume on perioperative outcomes in non-small cell lung cancer patients undergoing video-assisted thoracoscopic lobectomy: a randomized controlled trial
Translational Lung Cancer Research
2026;
15
(1)
:7
.
(31 January 2026)
Retrospective study on the tolerability using a four-cycle completion in elderly patients with extensive-stage small-cell lung cancer: a body mass index-based analysis
Translational Lung Cancer Research
2026;
15
(1)
:8
.
(31 January 2026)
Clinicopathological characteristics associated with intrapulmonary metastasis rather than single primary lung cancer at first diagnosis: a study based on the Surveillance, Epidemiology, and End Results database using Bayesian networks and structural equation modeling
Translational Lung Cancer Research
2026;
15
(1)
:9
.
(31 January 2026)
TP53 co-mutations are associated with elevated PD-L1 expression and high tumor mutational burden in non-small cell lung cancer: insights from comprehensive genomic profiling
Translational Lung Cancer Research
2026;
15
(1)
:10
.
(31 January 2026)
Feasibility of multimodality treatment, including pleurectomy decortication, in carefully selected patients with sarcomatoid mesothelioma
Translational Lung Cancer Research
2026;
15
(1)
:11
.
(31 January 2026)
RACGAP1 defines a malignant proliferative niche and represents a therapeutic vulnerability in lung adenocarcinoma
Translational Lung Cancer Research
2026;
15
(1)
:12
.
(31 January 2026)
Clinical implications of plasma EGFR T790M and ctDNA shedding across metastatic sites in plasma- or tissue-confirmed EGFR-mutant non-small cell lung cancer treated with lazertinib: a prospective multicenter cohort study
Translational Lung Cancer Research
2026;
15
(1)
:13
.
(31 January 2026)
Immune checkpoint inhibitor rechallenge in advanced NSCLC: prognostic value of the neutrophil-to-lymphocyte ratio
Translational Lung Cancer Research
2026;
15
(1)
:14
.
(31 January 2026)
Efficacy and mechanisms of cisplatin and sulforaphane nanoparticles in alleviating cisplatin resistance in non-small cell lung cancer
Translational Lung Cancer Research
2026;
15
(1)
:15
.
(31 January 2026)
circ-UBR5 in hypoxia-induced exosomes may mediate lung adenocarcinoma metastasis via the targeting of HNRNPR
Translational Lung Cancer Research
2026;
15
(1)
:16
.
(31 January 2026)
CD4+CXCL13+ exhausted T cells drive immune microenvironment divergence in synchronous double primary lung adenocarcinoma with different degrees of invasiveness
Translational Lung Cancer Research
2026;
15
(1)
:17
.
(31 January 2026)
Construction and validation of a CT-based radiomics-deep learning signature for non-invasive prediction of PD-L1 expression and immunotherapy outcomes in non-small cell lung cancer
Translational Lung Cancer Research
2026;
15
(1)
:18
.
(31 January 2026)
Review Article
Pathophysiology and treatment of leptomeningeal metastases in lung cancer
Translational Lung Cancer Research
2026;
15
(1)
:19
.
(31 January 2026)
Utility of various programmed death-ligand 1 (PD-L1) assays in predicting the clinical benefit of immune checkpoint inhibitors in PD-L1-expressing non-small-cell lung cancer patients: a systematic review
Translational Lung Cancer Research
2026;
15
(1)
:20
.
(31 January 2026)
Case Report
A comprehensive clinical trajectory of EGFR A763_Y764insFQEA-positive non-small cell lung cancer treated with fifth-line osimertinib following circulating tumor DNA-based detection: a case report
Translational Lung Cancer Research
2026;
15
(1)
:21
.
(31 January 2026)
Comprehensive genomic profiling of synchronous invasive adenocarcinoma and squamous cell carcinoma within the same lobe: a case report
Translational Lung Cancer Research
2026;
15
(1)
:22
.
(31 January 2026)
Letter to the Editor
Clarifying design, safety, and immune correlates in short-course hypofractionated radiotherapy for limited-stage small-cell lung cancer
Translational Lung Cancer Research
2026;
15
(1)
:23
.
(31 January 2026)
